Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wnt breakers in colon cancer.

Hans Clevers1

  • 1Hubrecht Laboratory, 3584 CT Utrecht, The Netherlands. clevers@niob.knaw.nl

Cancer Cell
|January 30, 2004
PubMed
Summary

Researchers are searching for small molecules to inhibit the Wnt signaling pathway, a key driver in colorectal cancer. Disrupting beta-catenin/Tcf4 interactions could offer a new strategy for smart anticancer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease.

Scientific reports·2020
Same author

An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.

The EMBO journal·2020
Same author

Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression.

Nature·2020
Same author

Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.

Nature protocols·2020
Same author

Translation and Replication Dynamics of Single RNA Viruses.

Cell·2020
Same author

CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids.

Cell stem cell·2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The Wnt signaling pathway is crucial in cell development and is frequently dysregulated in colorectal cancer.
  • Mutations in genes like APC lead to aberrant beta-catenin/Tcf4 complex formation, promoting cancer cell proliferation.
  • Targeting the beta-catenin/Tcf4 protein-protein interaction is a proposed strategy to reverse cancer phenotypes.

Discussion:

  • This study investigates high-throughput screening of compound libraries to identify inhibitors of the Wnt cascade.
  • The focus is on finding small molecules that can disrupt the critical beta-catenin/Tcf4 interaction.
  • Such inhibitors represent a potential novel class of targeted anticancer therapeutics.

Key Insights:

  • Identification of small molecules capable of inhibiting the Wnt signaling cascade.
  • Demonstration of the feasibility of targeting the beta-catenin/Tcf4 protein-protein interaction.
  • Validation of high-throughput screening as a method for discovering Wnt pathway inhibitors.

Outlook:

  • Development of novel, targeted therapies for colorectal cancer.
  • Potential for 'smart' anticancer drugs that specifically interfere with cancer-driving pathways.
  • Further research into the efficacy and safety of identified Wnt cascade inhibitors.

Related Experiment Videos